Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE)

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

First patient treated (si apre in una nuova finestra)

First patient treated.

IMP production final (si apre in una nuova finestra)

Production of IMP for clinical trial final.

Clinical trial kick-off (si apre in una nuova finestra)

Clinical Trial Kick-off meeting with all clinical partners.

International workshop (si apre in una nuova finestra)

Arrangements for an international scientific workshop on stem cell-based treatment of cardiac disease.

Monitoring of clinical sites (si apre in una nuova finestra)

Monitoring of clinical sites.

Status on posting of results (si apre in una nuova finestra)

Report on the status of the posting of results (to the study registry).

Training logs (si apre in una nuova finestra)

Training logs for personnel complete

Quantification of cardiac fibrosis (si apre in una nuova finestra)

A clinically applicable technique to determine and quantify cardiac fibrosis by MRI

Determination of local deformation parameters (si apre in una nuova finestra)

Easy to use protocol for 3D echocardiography to determine local deformation parameters. Use the local myocardial deformation to assess the local effects of cardiac regenerative therapy on local cardiac function

Comprehensive cost-PU effectiveness (si apre in una nuova finestra)

Comprehensive cost-PU effectiveness: Using country comparisons results and refinement of methods, a conclusive assessment of the economic effects of ASC therapy can be given.

Planning tool for cardiac cell therapy (si apre in una nuova finestra)

Validation of a novel treatment planning tool for cardiac cell therapy, that is based on real time image integration

IP management (si apre in una nuova finestra)

IP management final.

Dissemination (si apre in una nuova finestra)

Dissemination to relevant groups and meetings. Production technology published in peer reviewed journal. Clinical trial design published in peer reviewed journal.

Preliminary cost-effectiveness analysis (si apre in una nuova finestra)

First preliminary results of health economics: Standard cost-effectiveness analysis of ASC therapy for each country involved, analysis of country differences

All approvals package (si apre in una nuova finestra)

All approvals from national ethics committees and national competent authorities of all study sites recieved.

Method for a financial analysis (si apre in una nuova finestra)

Developed tools: A methodology for a financial analysis of innovative medical technology will be set up comprising a software tool to be used on the spot by the developers of the technologies

Qualification of production facility (si apre in una nuova finestra)

Documentation of proper classification for sterile GMP production.

Website (si apre in una nuova finestra)

Establishment of SCIENCE website for public and partner use.

Pubblicazioni

Intracoronary autologous bone marrow cell transfer after acute myocardial infarction: abort and refocus (si apre in una nuova finestra)

Autori: Jozef Bartunek, Wojtek Wojakowski
Pubblicato in: European Heart Journal, Numero 38/39, 2017, Pagina/e 2944-2947, ISSN 0195-668X
Editore: Oxford University Press
DOI: 10.1093/eurheartj/ehx300

Global position paper on cardiovascular regenerative medicine (si apre in una nuova finestra)

Autori: Francisco Fernández-Avilés, Ricardo Sanz-Ruiz, Andreu M. Climent, Lina Badimon, Roberto Bolli, Dominique Charron, Valentin Fuster, Stefan Janssens, Jens Kastrup, Hyo-Soo Kim, Thomas F. Lüscher, John F. Martin, Philippe Menasché, Robert D. Simari, Gregg W. Stone, Andre Terzic, James T. Willerson, Joseph C. Wu, Francisco Fernández-Avilés, Andre Terzic, Lina Badimon, Kathleen Broughton, Darcy L
Pubblicato in: European Heart Journal, Numero 38/33, 2017, Pagina/e 2532-2546, ISSN 0195-668X
Editore: Oxford University Press
DOI: 10.1093/eurheartj/ehx248

Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) (si apre in una nuova finestra)

Autori: Christina Paitazoglou, Martin W. Bergmann, Bojan Vrtovec, Steven A.J. Chamuleau, Bas van Klarenbosch, Wojtek Wojakowski, Aleksandra Michalewska-Włudarczyk, Mariann Gyöngyösi, Annette Ekblond, Mandana Haack-Sørensen, Kai Jaquet, Karsten Vrangbaek, Jens Kastrup
Pubblicato in: European Journal of Heart Failure, 2019, ISSN 1388-9842
Editore: Elsevier BV
DOI: 10.1002/ejhf.1412

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations (si apre in una nuova finestra)

Autori: Francisco Fernández-Avilés, Ricardo Sanz-Ruiz, Andreu M. Climent, Lina Badimon, Roberto Bolli, Dominique Charron, Valentin Fuster, Stefan Janssens, Jens Kastrup, Hyo-Soo Kim, Thomas F. Lüscher, John F. Martin, Philippe Menasché, Fausto J. Pinto, Robert D. Simari, Gregg W. Stone, Andre Terzic, James T. Willerson, Joseph C. Wu
Pubblicato in: Circulation Research, Numero 122/2, 2018, Pagina/e 199-201, ISSN 0009-7330
Editore: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circresaha.117.312099

Diritti di proprietà intellettuale

STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS

Numero candidatura/pubblicazione: 20 16075407
Data: 2016-10-21
Candidato/i: REGION HOVEDSTADEN

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile

Il mio fascicolo 0 0